http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019115670-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f9b0a5a62d169b27b870c5ed2bd23ad
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06V40-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-1124
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2021-0077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-162
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2021-0044
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0663
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4836
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4839
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0618
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4082
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0082
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M21-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06
filingDate 2019-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9f89a2985ebad5d0b2f85c769daded1
publicationDate 2019-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2019115670-A
titleOfInvention How to prevent and treat exercise related neurological disorders
abstract The present invention provides a method for preventing or treating exercise-related neurological disorders. The method comprises using ocular light therapy in conjunction with conventional therapy for exercise related neurological disorders such as a dosing regimen to adjust levels of melatonin and / or dopamine in the subject's body. The phototherapy of the eye can include high levels of blue-green or green light (e.g., light within the wavelength range of 460 nm to 570 nm, 490 nm to 570 nm, about 520 nm to 570 nm, etc.), low levels of amber, orange, And / or may include red light. In addition, the method of examining exercise related neuropathy is subject to one or more symptoms of any exercise related neuropathy associated with exercise that the subject is susceptible to or may have already experienced by the use of eye light therapy The target includes a temporary indication. [Selected figure] Fig. 18
priorityDate 2011-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001503394-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010526645-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010531810-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID184946
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID198914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439260
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID184946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457574860
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544741
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492817
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507128
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID198914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID896

Total number of triples: 38.